{"id":12459,"date":"2026-06-22T10:56:46","date_gmt":"2026-06-22T10:56:46","guid":{"rendered":"https:\/\/facesconsent.com\/blog\/?p=12459"},"modified":"2026-06-22T18:53:37","modified_gmt":"2026-06-22T18:53:37","slug":"sourcing-hyaluronidase-the-right-way-in-the-uk","status":"publish","type":"post","link":"https:\/\/facesconsent.com\/blog\/sourcing-hyaluronidase-the-right-way-in-the-uk\/","title":{"rendered":"Sourcing Hyaluronidase the Right Way in the UK"},"content":{"rendered":"\n

Most practitioners<\/mark><\/a> think of hyaluronidase<\/mark><\/a> as the thing you reach for when a lip looks overfilled. That is the easy half of the job. The hard half is having genuine, in-date, correctly stored stock on the shelf the day a vascular occlusion turns up, because that is the use that decides whether tissue survives. The two jobs are the same enzyme and almost nothing else, and the gap between treating them as one thing and treating them as two is where clinics get caught out. Sourcing it properly, and legally, is the first step in closing that gap.<\/p>\n\n\n\n

What hyaluronidase is and why every filler clinic needs it?<\/h2>\n\n\n\n

Hyaluronidase is an enzyme that breaks down hyaluronic acid. It hydrolyses the bonds holding HA chains together, unfolding the molecule so the body can absorb it. That makes it the direct reversal agent for the HA fillers<\/mark><\/a> that dominate UK practice. It works on both the cross-linked HA in filler and the body’s own native HA, which is why minimum effective dosing matters in elective cases and why patients should be warned about temporary loss of natural volume alongside the product.<\/p>\n\n\n\n

It serves two clinically separate purposes. The first is elective correction: overfilling, asymmetry, migration, lumps, Tyndall effect or a patient who simply wants their filler reversed. The second is emergency management of vascular occlusion, where filler has blocked or compressed a facial artery and tissue is at risk. These two uses share a drug but almost nothing else. The dosing, urgency and technique differ completely, and confusing one for the other is a serious error. <\/p>\n\n\n\n

\"Woman<\/figure>\n\n\n\n

The legal position, and why “where to buy” is the wrong first question<\/h2>\n\n\n\n

In the UK, hyaluronidase is a prescription-only medicine (POM)<\/mark><\/a>. That single fact shapes everything about how it is sourced. A POM cannot be bought off the shelf the way filler can. It has to be prescribed for a named patient, or held as stock under a lawful arrangement, by someone with prescribing rights<\/mark><\/a>: a doctor, dentist, independent prescribing nurse or independent prescribing pharmacist.<\/p>\n\n\n\n

This is where many non-medical injectors hit a wall. A beauty therapist or non-prescribing practitioner cannot lawfully obtain or hold their own supply. They need a prescriber<\/mark><\/a> involved. That is not a bureaucratic nuisance to be worked around. It is the legal structure, and it exists because this drug carries a real risk of anaphylaxis and is used in situations where minutes matter. The forthcoming licensing of fillers in England, covered in the House of Commons Library briefing on non-surgical cosmetic procedures<\/mark><\/a>, is expected to tighten exactly this point, with prescriber oversight a central theme.<\/p>\n\n\n\n

So the honest answer to “where do I buy hyaluronidase<\/em>” is: through a legitimate route that runs through a prescriber and a licensed pharmacy. Anything that lets you skip that, an overseas website shipping vials with no prescription, a social media seller, a “no questions asked” supplier, should be treated as a red flag. Counterfeit and unlicensed stock is a known problem, and an antidote you cannot trust is worse than useless in an emergency.<\/p>\n\n\n\n

One related governance point that catches injectors out: indemnity. Holding and administering a POM, and managing an occlusion, both need to sit inside your insurance cover. Many policies treat emergency hyaluronidase administration as a specific activity, so it is worth confirming your indemnity through a provider such as companies listed as Faces’ insurance<\/mark><\/a> partners covers both elective dissolving and emergency<\/mark><\/a> use before you stock a single vial.<\/p>\n\n\n\n

How to buy hyaluronidase legitimately<\/h2>\n\n\n\n

For a prescribing practitioner, the route is straightforward: order genuine, in-date stock from a licensed UK pharmacy<\/mark><\/a> and hold it under proper medicines governance. For a non-prescriber, the route runs through a named prescriber who assesses the patient, and issues the prescription. Either way, the supplier should be a UK-licensed pharmacy that only releases POMs against a valid prescription. The option to buy hyaluronidase online exists and is convenient, but the legality lives in the prescription behind the order, not the website’s checkout.<\/p>\n\n\n\n

The products: Hyalase and Disolvidase<\/h2>\n\n\n\n

Two names come up most often. Hyalase is the long-established UK preparation, ovine-derived hyaluronidase supplied as 1,500 IU of lyophilised powder per ampoule for reconstitution. It is the product the UK consensus guidance is written around, and most practitioners learn on it.<\/p>\n\n\n\n

Hyalase<\/mark><\/a> has the longest real-world track record of any hyaluronidase product in UK aesthetic practice, which is part of why it remains the default reference point. Being ovine-derived (sourced from sheep), it carries the allergy considerations that sit behind the standard patch-testing advice, and its dosing, reconstitution and storage are exactly what the consensus protocols describe. For most practitioners it is the benchmark every other preparation is measured against, and a clinic that stocks it is working with the product the guidance was written for. Faces lists Hyalase<\/mark><\/a> alongside the other dissolvers in its pharmacy, released against a valid prescription.<\/p>\n\n\n\n

Disolvidase<\/mark><\/a> is a more recent hyaluronidase preparation, also supplied as a 1,500 IU freeze-dried powder for solution, marketed for dissolving HA fillers and managing overcorrection, nodules and filler-related tissue ischaemia. It sits in the same therapeutic space and is reconstituted and dosed on the same principles. Whichever brand a clinic stocks, the active ingredient and the clinical reasoning are the same.<\/p>\n\n\n\n

A practical aside on search terms: practitioners hunting for stock type all sorts of variants. A hyaluronidase dissolver, a filler dissolver, a lip filler dissolver or a hyaluronidase filler dissolver are all describing the same enzyme. The terminology varies; the drug does not. What matters is buying a genuine, in-date, properly stored product from a lawful source.<\/p>\n\n\n\n

Preparation, dosing and sharps<\/h3>\n\n\n\n

Hyalase comes as a white powder that must be reconstituted before use. The standard approach reconstitutes 1,500 IU in 1ml of diluent. Saline is preferred over water for injection because it stings less, and bacteriostatic saline is often chosen for its mild anaesthetic property, though that use is itself off-licence. Mix gently by drawing up and expelling rather than shaking hard, since vigorous agitation foams the solution. Once reconstituted, use it promptly and discard any unused contents.<\/p>\n\n\n\n

The volume of diluent is not fixed. A range of 1 to 10ml is used in practice, chosen according to the area and how diffuse or focused the dissolution needs to be. Larger volumes spread the enzyme over a wider field; smaller, more concentrated preparations target a defined nodule.<\/p>\n\n\n\n

A widely cited consensus figure is that roughly five units of hyaluronidase will break down 0.1ml of 20mg\/ml HA, though the real-world range is broad. Dosing in aesthetics is off-label, so there is no manufacturer dose table. The accepted principle is to inject as much as needed to achieve the effect rather than chase a fixed number, titrating to the tissue in front of you. A 30G needle suits most elective work, placed accurately into and around the target filler, with firm massage afterwards to aid mechanical breakdown.<\/p>\n\n\n\n

Reconstituting ampoules and injecting means needles<\/mark><\/a>, glass and used vials, so a compliant sharps and clinical-waste route is part of doing this safely and legally. Practitioners can connect with partner waste-management companies<\/mark><\/a> directly on Faces to arrange compliant collection and disposal.<\/p>\n\n\n\n

The emergency dose is different<\/h3>\n\n\n\n

Vascular occlusion is not treated with elective doses. The high-dose, pulsed protocol established in the published literature represented a deliberate move away from cautious underdosing toward aggressive, immediate enzymatic dissolution along the course of the affected vessel, repeated at intervals until perfusion returns. For suspected occlusion the reflex must never be to reach for the small elective dose. If visual symptoms appear, that is a sight-threatening emergency requiring immediate transfer to a hospital eye unit, with retrobulbar hyaluronidase considered only by those with specific competence while awaiting transfer.<\/p>\n\n\n\n

Two things make the difference between a controlled save and a panic. The first is competence: if your training never drilled occlusion recognition and high-dose protocols, that is a gap to close before it is tested. Through our training academy partners, practitioners can find and contact training providers<\/mark><\/a> directly on the platform to book courses. The second is access to senior help in the moment. Complications Consultant<\/mark><\/a> gives a practitioner someone to call when the cheek is mottling and a decision is needed fast. Any clinic injecting filler should also keep a written occlusion protocol and enough stock to deliver the emergency dose, not a single elective vial.
<\/p>\n\n\n\n

Allergy, patch testing and consent<\/h2>\n\n\n\n

Hyaluronidase can cause allergic reactions, including, rarely, anaphylaxis. UK consensus guidance recommends a skin patch test before elective dissolution, read after an appropriate interval, with the patient then observed in clinic for around 60 minutes after treatment. In a genuine vascular emergency, treatment is not delayed for patch testing; the risk calculus flips entirely.<\/p>\n\n\n\n

Caution applies in patients with a history of significant allergy, particularly to bee or wasp venom, which is associated with raised sensitivity to hyaluronidase. It is generally avoided in pregnancy and breastfeeding, and around active infection at the site. Patients must be counselled that the enzyme also removes some natural HA, that results can take up to two weeks to settle, and that more than one session may be needed. The point about non-HA products is worth stating plainly to patients who arrive confused: hyaluronidase does nothing to Sculptra<\/mark><\/a>, Radiesse<\/mark><\/a>, silicone or other non-HA fillers.<\/p>\n\n\n\n

Because the risks are specific and the consent conversation detailed, a dedicated dissolving consent record matters here more than a generic one. A purpose-built dissolving consent form<\/mark><\/a> that documents the patch test, the anaphylaxis risk and the volume-loss counselling protects both patient and practitioner.<\/p>\n\n\n\n

\"Practitioner<\/figure>\n\n\n\n

Storage, stock management and aftercare<\/h2>\n\n\n\n

This is where governance quietly protects patients. Hyaluronidase should be stored cool, at 2 to 8\u00b0C, to preserve potency over time. Held at room temperature its stability is only guaranteed for around 12 months. A vial that has degraded in a warm drawer is the worst kind of false security, present but ineffective. Stock should be logged, kept in date, stored correctly and checked before every filler session. Treating availability as a non-negotiable part of session preparation, rather than an optional extra, is the standard the consensus guidance sets.<\/p>\n\n\n\n

Patients leaving after dissolving<\/mark><\/a> need clear written guidance too, covering expected swelling, what is normal in the first 72 hours, and the warning signs that should prompt them to make contact. A ready-made aftercare form<\/mark><\/a> saves rewriting it each time and gives the patient something to refer back to.<\/p>\n\n\n\n

How long does it take to work?<\/h2>\n\n\n\n

This is the question patients ask most, and the honest answer is that it is faster than they fear but slower than the before-and-after photos suggest. The enzyme begins acting almost immediately, but visible change builds over hours to days.<\/p>\n\n\n\n

On how long does filler take to dissolve with hyaluronidase, most elective cases show clear improvement within 24 to 48 hours, with the final result settling over one to two weeks as residual product clears and swelling resolves. Densely cross-linked or large-volume placements may need repeat sessions. On the narrower question of how long does lip filler take to dissolve with hyaluronidase, lips tend to respond quickly because the tissue is mobile and well perfused, often softening within a day or two, though swelling from the injection itself can briefly mask the result. Setting that expectation in advance prevents a worried message at the 48-hour mark. The Faces guide to how long it takes to dissolve fillers<\/mark><\/a> <\/mark>is a useful piece to share with patients directly.<\/p>\n\n\n\n

Building the dissolving side of your service properly<\/h2>\n\n\n\n

Dissolving is increasingly a treatment patients seek out in its own right, not just a correction tool, so it is worth setting up as a proper service line rather than an afterthought. That means listing it in your bookable treatments<\/mark><\/a> with accurate timings that account for the patch-test wait, and using a booking system that can build in the 60-minute observation window so the diary is not derailed. A platform like Faces that handles bookings, offers patient finance<\/mark><\/a> for larger correction packages, and keeps the figures straight means the admin around a clinically demanding treatment is not adding to the load.<\/p>\n\n\n\n

Get the antidote sorted before the next syringe<\/h2>\n\n\n\n

Stock should be in the fridge before a patient is ever booked, not ordered in a panic. Faces supplies genuine Hyalase and Disolvidase, released against valid prescriptions from UK-licensed pharmacies, with next-day delivery so cover is never the reason a session is delayed. For non-prescribers, Faces can connect you with a prescriber to authorise supply and oversee governance. Sort the prescriber, the stock, the storage, the consent and the cover now, so the only thing you are thinking about at 7pm is the patient.<\/p>\n\n\n\n

FAQs<\/h2>\n\n\n
\n
\n
\n

Can I buy hyaluronidase without a prescription?<\/strong><\/p>\n

\n\n

No. In the UK, hyaluronidase is a prescription-only medicine (POM) and cannot be bought off the shelf like filler. It must either be prescribed for a named patient or held as stock under a lawful arrangement by a prescriber \u2014 a doctor, dentist, independent prescribing nurse or independent prescribing pharmacist. A non-prescribing injector must involve a prescriber who assesses the patient and issues the prescription. Any route that lets you skip that step should be treated as a red flag for counterfeit or unlicensed stock.<\/p>\n\n<\/div>\n<\/div>\n

\n

What’s the difference between Hyalase and Disolvidase?<\/strong><\/p>\n

\n\n

Both contain the same active enzyme and are dosed on the same principles. Hyalase is the long-established UK preparation \u2014 ovine-derived (from sheep), supplied as 1,500 IU of freeze-dried powder per ampoule. It has the longest track record in UK aesthetic practice and is the product the consensus guidance is written around, so it’s the benchmark others are measured against. Disolvidase is a more recent 1,500 IU freeze-dried preparation in the same therapeutic space. Whichever you stock, the active ingredient and clinical reasoning are identical.<\/p>\n\n<\/div>\n<\/div>\n

\n

Does it dissolve every type of filler?<\/strong><\/p>\n

\n\n

No. Hyaluronidase only works on HA fillers. It does nothing to Sculptra, Radiesse, silicone or other non-HA products \u2014 worth stating plainly to patients who arrive confused about what can be reversed.<\/p>\n\n<\/div>\n<\/div>\n

\n

How long does it take to work?<\/strong><\/p>\n

\n\n

The enzyme begins acting almost immediately, but visible change builds over hours to days. Most elective cases show clear improvement within 24 to 48 hours, with the final result settling over one to two weeks as residual product clears and swelling resolves. Lips tend to respond quickly because the tissue is mobile and well perfused, often softening within a day or two, though injection swelling can briefly mask the result. Densely cross-linked or large-volume placements may need repeat sessions.<\/p>\n\n<\/div>\n<\/div>\n

\n

How should it be stored?<\/strong><\/p>\n

\n\n

Store it cool, at 2 to 8\u00b0C, to preserve potency. At room temperature its stability is only guaranteed for around 12 months, and a vial degraded in a warm drawer is the worst kind of false security \u2014 present but ineffective. Stock should be logged, kept in date, stored correctly and checked before every filler session.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n

\n
SHOP NOW<\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Most practitioners think of hyaluronidase as the thing you reach for when a lip looks overfilled. That is the easy half of the job. The hard half is having genuine, in-date, correctly stored stock on the shelf the day a vascular occlusion turns up, because that is the use that decides whether tissue survives. The […]<\/p>\n","protected":false},"author":6,"featured_media":12462,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[20],"tags":[12,1052,1051,259,10,306,14,227],"class_list":["post-12459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aesthetics","tag-aesthetics","tag-disolvidase","tag-hyalase","tag-hyaluronidase","tag-medical-practitioners","tag-toxin","tag-treatment","tag-uk"],"_links":{"self":[{"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/posts\/12459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/comments?post=12459"}],"version-history":[{"count":5,"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/posts\/12459\/revisions"}],"predecessor-version":[{"id":12483,"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/posts\/12459\/revisions\/12483"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/media\/12462"}],"wp:attachment":[{"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/media?parent=12459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/categories?post=12459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/facesconsent.com\/blog\/wp-json\/wp\/v2\/tags?post=12459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}